OBJECTIVE: Assess if microbes in clean catch urine of pregnant women resemble those of the vagina or the lower urinary tract. STUDY DESIGN: This is a prospective IRB-approved cohort study of 29 pregnant women with a singleton pregnancy <14 weeks. Exclusion criteria included recurrent UTI, antibiotic use since conception, and urinary tract anomalies. During their 1 st trimester visit, consented subjects provided paired clean catch urine and vaginal swab samples. Samples were assessed by an Expanded Quantitative Culture (EQC) method that -compared to the standard urine culture method -uses more types of media and atmospheric conditions with a longer incubation period. Colony forming units (CFU) were counted for each morphologically distinct colony type; representative colonies were purified for identification using MALDI-TOF Mass Spectroscopy. Species identification and CFU counts were combined for analysis using the Bray-Curtis dissimilarity index (BC). A BC value of 0.5 was used to sort paired vaginal and urine samples as similar (<0.5) or different (0.5). For descriptive purposes, samples were hierarchically clustered with complete-linkage agglomeration by their vaginal culture results. RESULTS: The majority of the subjects were multiparous (n¼20) with a mean age of 29.6 years. EQC detected live microbes in both urine and vaginal samples of all subjects. The vaginal samples clustered into 4 distinct community state structures (Figure) . Based on BC indices, paired urine and vaginal samples were dissimilar (BC0.5) for 72% (n¼21) of subjects. Of the 8 subjects with similar urine and vaginal microbiomes (BC<0.5), Lactobacillus was dominant in 88% of vaginal samples (n¼7) and 100% of urine samples (n¼8). In contrast, of the 21 subjects with dissimilar microbiomes (BC>0.5), a minority (24%, n¼5) had a Lactobacillus-dominant urine sample (p<0.01). CONCLUSION: The clean catch urine microbiome of pregnant women in their 1 st trimester is most often distinct from their vaginal microbiome, evidence that their lower urinary tract contains a unique microbiome. Women with dissimilar urine and vaginal microbiomes were less likely to have Lactobacillus-dominant urine. Given these findings, the vaginal microbiome should not be assumed to represent the lower urinary tract microbiome.
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Poster Session III OBJECTIVE: HIV-infected pregnant women have high rates of preterm birth (PTB). Multiple recent reports have suggested, counterintuitively, that women who start antiretroviral therapy (ART) prior to conception have higher rates of PTB than women who initiate ART in pregnancy. We hypothesized that this association, if real, is not mediated through inflammation and immune activation in the vagina and peripheral blood. STUDY DESIGN: We analyzed specimens from an ongoing prospective cohort study in Lusaka, Zambia. At the time of analysis, paired (vaginal, plasma) mid-trimester (16-20 weeks) samples from 494 women were available. To maximize information with available budget for this sub-study, we analyzed all specimens from HIV seropositive women and a random sample of HIV negative women, accounting for this with probability weighting in analyses. We further divided HIVinfected women into those on preconceptional ART versus those who started ART during pregnancy (after samples obtained). We measured a panel of 13 maternal plasma and 14 maternal vaginal fluid analytes using a multiplex immunoassay (MilliporeSigma, Darmstadt, Germany). We log-transformed concentrations and compared them across exposure categories with ANOVA. RESULTS: We analyzed 244 plasma specimens (153 HIV-uninfected, 51 HIV-infected on preconceptional ART, and 40 HIV-infected without preconceptional ART exposure) and 255 vaginal swabs (160 HIVuninfected, 54 HIV-infected on preconceptional ART, and 41 HIVinfected without preconceptional ART exposure). When compared to HIV-uninfected women and HIV-infected women on preconceptional ART, women not on preconceptional ART had significantly higher concentrations of inflammatory plasma (IP10, IL-8, IFN-ɣ, IL12p40, and sCD14) and vaginal (IL-1b, IL-10, sCD14) biomarkers as well as significantly lower concentrations of anti-inflammatory TGF-b in plasma and vaginal SLPI, an enzyme with anti-HIV properties (p< 0.05; no adjustment for multiple comparisons; Table) .
CONCLUSION: HIV-infected pregnant women without preconceptional ART exposure exhibited increased systemic and local inflammation in the second trimester of pregnancy. If recent reports associating preconceptional ART with PTB are correct, our study suggests the mechanism is not early local or systemic inflammation. Additional analyses to understand the interaction between these inflammatory markers, other PTB risk factors, and the vaginal microbiota are ongoing.
